Ali M. Bozorg

Neurology

8010 Arco Corporate Dr Ste 175
Raleigh, NC 27617

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.

Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 30, 2023

Pitfalls of using video-EEG for a trial endpoint in children aged <4 years with focal seizures.

Pitfalls of using video-EEG for a trial endpoint in children aged <4 years with focal seizures.

Journal: Annals of clinical and translational neurology

Published: August 16, 2023

Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures.

Efficacy and tolerability of adjunctive lacosamide in patients aged <4 years with focal seizures.

Journal: Annals of clinical and translational neurology

Published: August 16, 2023

Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open-label exploratory trial.

Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open-label exploratory trial.

Journal: Epilepsia

Published: March 29, 2023

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.

Journal: The Lancet. Neurology

Published: November 11, 2022

Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey.

Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey.

Journal: Orphanet journal of rare diseases

Published: September 23, 2022

Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

Journal: Epilepsia open

Published: August 02, 2022

Healthcare resource use in myasthenia gravis: a US health claims analysis.

Healthcare resource use in myasthenia gravis: a US health claims analysis.

Journal: Therapeutic advances in neurological disorders

Published: May 03, 2022

Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey.

Physician-Reported Perspectives on Myasthenia Gravis in the United States: A Real-World Survey.

Journal: Neurology and therapy

Published: April 01, 2022

Treatment patterns in myasthenia gravis: A United States health claims analysis.

Treatment patterns in myasthenia gravis: A United States health claims analysis.

Journal: Muscle & nerve

Published: January 26, 2022

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.

Journal: Epilepsia

Published: November 30, 2021

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials.

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials.

Journal: Epilepsia open

Published: August 06, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026